Spring Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.19 M
- Revenue Growth -38.39%
- Profit Growth -51.46%
- Ebitda -44.21%
- Net Worth 9.11%
- Total Assets -23.51%
About Spring Life Sciences
Spring Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2017 (Seven years and ten months 1 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.19 M.
Ajit Deval and Anjali Deval serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85200MH2017PTC294270
- Company No.
294270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Spring Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Deval  | Additional Director | 20-Jan-2023 | Current |
| Anjali Deval | Director | 12-Sep-2017 | Current |
Financial Performance of Spring Life Sciences.
Spring Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 38.39% decrease. The company also saw a substantial fall in profitability, with a 51.46% decrease in profit. The company's net worth moved up by a moderate rise of 9.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spring Life Sciences?
In 2023, Spring Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clara Ventures LlpAnjali Deval is a mutual person
- Anjali & Ananya Fertility Llp
Anjali Deval is a mutual person
- Nivian Life Sciences Private Limited
Anjali Deval is a mutual person
Charges (Loans)
₹0.32 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2018 | Others | ₹2.10 M | Open |
| 29 Sep 2017 | Others | ₹1.09 M | Open |
How Many Employees Work at Spring Life Sciences?
Unlock and access historical data on people associated with Spring Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spring Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spring Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
